Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication November 4, 2015
- Accepted for publication December 4, 2015
- Published online April 1, 2016.
Article Versions
- previous version (January 14, 2016 - 06:06).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Kambiz Rahbar1,
- Matthias Weckesser1,
- Sebastian Huss2,
- Axel Semjonow3,
- Hans-Jörg Breyholz1,
- Andres J. Schrader3,
- Michael Schäfers1,4,5 and
- Martin Bögemann3
- 1Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany
- 2Gerhard Domagk Institute of Pathology, University Hospital Muenster, Muenster, Germany
- 3Prostate Center, Department for Urology, University Hospital Muenster, Muenster, Germany
- 4European Institute for Molecular Imaging, University of Muenster, Muenster, Germany; and
- 5Cells-in-Motion Cluster of Excellence, University of Muenster, Muenster, Germany
- For correspondence or reprints contact: Kambiz Rahbar, Department of Nuclear Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany. E-mail: rahbar{at}uni-muenster.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Diagnostic Performance of [18F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference Standard
- A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
- Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
- Tumor Detection of 18F-PSMA-1007 in the Prostate Gland in Patients with Prostate Cancer Using Prostatectomy Specimens as Reference Method
- Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
- qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT
- Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
- Combination of 68Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis
- EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT
- Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer
- Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study
- PSMA Ligands for PET Imaging of Prostate Cancer
- Phase 2 Study of 99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection
- Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
- 68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept
- German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
- What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer
- Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis